abstract |
New compounds of formula (I) are provided wherein R1, R2, R4, R5, G1, G2, L, Y and n are as defined in the specification and optical isomers, racemates and tautomers thereof, and pharmaceutically acceptable salts thereof; together with a process for their preparation, compositions containing them and their use in treatment. The compounds are inhibitors of neutrophil elastase. |